Literature DB >> 14746935

Intracranial pathology of the visual pathway.

W Müller-Forell1.   

Abstract

Intracranial pathologies involving the visual pathway are manifold. Aligning to anatomy, the most frequent and/or most important extrinsic and intrinsic intracranial lesions are presented. Clinical symptoms and imaging characteristics of lesions of the sellar region are demonstrated in different imaging modalities. The extrinsic lesions mainly consist of pituitary adenomas, meningeomas, craniopharyngeomas and chordomas. In (asymptomatic and symptomatic) aneurysms, different neurological symptoms depend on the location of aneurysms of the circle of Willis. Intrinsic tumors as astrocytoma of any grade, ependymoma and primary CNS-lymphoma require the main pathology in the course of the visual pathway. Vascular and demyelinating diseases complete this overview of intracranial lesions.

Entities:  

Mesh:

Year:  2004        PMID: 14746935     DOI: 10.1016/j.ejrad.2003.09.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

Review 1.  [Neuroradiology of the intracranial visual pathway. Part II].

Authors:  W Müller-Forell
Journal:  Radiologe       Date:  2005-11       Impact factor: 0.635

2.  Optic tract hemorrhage after pituitary apoplexy.

Authors:  H J Kim; W H Cho
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

3.  Neuro-Ophthalmic and Clinical Characteristics of Brain Tumours in a Tertiary Hospital in Ghana.

Authors:  N N Tagoe; V A Essuman; G Fordjuor; J Akpalu; P Bankah; T Ndanu
Journal:  Ghana Med J       Date:  2015-09

4.  Incidental optochiasmatic cavernoma: Case report of an unusual finding on 3 Tesla MRI.

Authors:  Mirko Trentadue; Roberto Pozzi Mucelli; Enrico Piovan; Francesca Benedetta Pizzini
Journal:  Neuroradiol J       Date:  2016-05-04

5.  In vivo diffusion tensor imaging of the human optic chiasm at sub-millimeter resolution.

Authors:  Joelle E Sarlls; Carlo Pierpaoli
Journal:  Neuroimage       Date:  2009-06-09       Impact factor: 6.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.